Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib vs Pazopanib plus Gemcitabine in Relapsed or Metastatic Soft Tissue Sarcoma
DRKS00003139Phase 2Completed
- Sponsor
- Universitätsmedizin Halle
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in soft tissue sarcoma (STS) comparing Pazopanib monotherapy with Pazopanib plus gemcitabine (2 arms). Started Jan 2012; status: completed.
02
Drugs
pazopanibgemcitabine
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on DRKS00003139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00003139.